1. Delays in treating endometrial cancer in the South West of England.
- Author
-
Johnson, N., Miles, T., Bailey, D., Tylko-Hill, K., Das, N., Ahson, G., Waring, K., Acheson, N., Voss, M., Gordon, J., Keates-Porter, S., Hughes, G., Golby, S., Fort, E., Newton, L., Nallaswamy, V., Murdoch, J., and Anderson, R.
- Subjects
UTERINE cancer ,MEDICAL care ,HOSPITAL admission & discharge ,CANCER in women ,SURVEYS ,CANCER treatment - Abstract
Background: Poor cancer survival rates in the United Kingdom are often blamed on delayed medical care. A local audit of endometrial cancer revealed a variety of preventable delays. We surveyed practice in the South West of England to see if this was an isolated or widespread problem.Methods: All 15 hospitals in the South West of England collected information prospectively from all women with endometrial cancer over 3 months in the spring of 2009.Results: There were delays in all stages of the uterine cancer pathway. Excluding extraneous cases, 52% of women waited more than a month and 12% waited more than 6 months to see their GP from the onset of symptoms. Almost half the cases said they were unaware that abnormal bleeding was a symptom of cancer. Only a quarter of women had treatment within 31 days from the outpatient visit to first definitive treatment and 18% waited more than the target of 62 days for their treatment.Conclusions: Significant treatment delays occur because women do not report bleeding. If this is replicated throughout Britain, approximately 1000 women per year will delay presentation for at least 3 months and 600 will wait for more than 6 months. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF